Buy Zydus Lifesciences, target price Rs 470: JM Financial

Zydus Lifesciences Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 42548.00 Crore) operating in Pharmaceuticals sector.

BCCL
Promoters held 74.98 per cent stake in the company as of 30-Sep-2022, while FIIs owned 2.86 per cent, DIIs 12.85 per cent.
JM Financial has buy call on Zydus Lifesciences with a target price of Rs 470. The current market price of Zydus Lifesciences Ltd. is Rs 420.05.

Zydus Lifesciences Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 42548.00 Crore) operating in Pharmaceuticals sector.

Zydus Lifesciences Ltd. key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2022.



Financials
For the quarter ended 30-09-2022, the company reported a Consolidated Total Income of Rs 4179.10 Crore, up .98 % from last quarter Total Income of Rs 4138.60 Crore and up 8.88 % from last year same quarter Total Income of Rs 3838.10 Crore. Company reported net profit after tax of Rs 511.30 Crore in latest quarter.

The company’s top management includes Mr.Pankaj R Patel, Dr.Sharvil P Patel, Mr.Ganesh N Nayak, Mr.Bhadresh K Shah, Mr.Mukesh M Patel, Mr.Nitin R Desai, Ms.Dharmishtaben N Raval, Ms.Apurva S Diwanji. Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-09-2022, the company has a total of 101 Crore shares outstanding.
ADVERTISEMENT



Promoter/FII Holdings
Promoters held 74.98 per cent stake in the company as of 30-Sep-2022, while FIIs owned 2.86 per cent, DIIs 12.85 per cent.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Buy Zydus Lifesciences, target price Rs 470: JM Financial
Text Size:AAA
Success
This article has been saved

*

+